Empowering cancer survivorship: collaboration and care

Advancements in paediatric Acute lymphoblastic leukemia management

Enhancing head and neck oncology: Key insights from the conference

Tusamitamab ravtansine versus docetaxel in previously treated advanced nonsquamous NSCLC: Results from phase 3 CARMEN-LC03 trial

Cemiplimab monotherapy could be a new treatment option for first line advanced NSCLC patients

Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients

Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies

Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC

Common Sense Oncology in head & neck cancers

CAR-T - Choosing Wisely

Reducing drug expenditures without harming patients

Surveillance imaging after curative-intent treatment for cancer- benefits, harms and evidence